ETx-22, a Novel Nectin-4-Directed Antibody-Drug Conjugate, Demonstrates Safety and Potent Antitumor Activity in Low-Nectin-4-Expressing Tumors
ETx-22 是一种新型 Nectin-4 靶向抗体药物偶联物，在低 Nectin-4 表达肿瘤中表现出安全性和强效抗肿瘤活性
期刊:Cancer Research Communications
影响因子:2
doi:10.1158/2767-9764.CRC-24-0176
Marc Lopez, Emerence Crompot, Emmanuelle Josselin, Anne Farina, Marion Rubis, Remy Castellano, Joanna Fares, Maria Wehbe, Yves Collette, Emmanuelle Charafe, Stéphanie Blanchin, François Romagne, Anikó Pálfi, Torsten Hechler, Andreas Pahl, Hatem A Azim Jr, Florence Lhospice, Emilie Mamessier, Françoi
